Clarmin Explorations Inc. Share Price Toronto S.E.
Equities
CYBN
CA23256X1006
Biotechnology & Medical Research
Sales 2024 * | - | Sales 2025 * | - | Capitalization | 35Cr 25Cr 2.1TCr |
---|---|---|---|---|---|
Net income 2024 * | -7.4Cr -5.4Cr -450.06Cr | Net income 2025 * | -7Cr -5.1Cr -425.73Cr | EV / Sales 2024 * | - |
Net cash position 2024 * | 17Cr 12Cr 1.04TCr | Net cash position 2025 * | 13Cr 9.17Cr 765.1Cr | EV / Sales 2025 * | - |
P/E ratio 2024 * |
-1.92
x | P/E ratio 2025 * |
-3.3
x | Employees | - |
Yield 2024 * |
-
| Yield 2025 * |
-
| Free-Float | 93.2% |
Latest transcript on Clarmin Explorations Inc.
Managers | Title | Age | Since |
---|---|---|---|
Douglas Drysdale
CEO | Chief Executive Officer | 54 | 01/20/01 |
Paul Glavine
FOU | Founder | 35 | 13/16/13 |
Eric So
FOU | Founder | 49 | 13/16/13 |
Members of the board | Title | Age | Since |
---|---|---|---|
Eric So
FOU | Founder | 49 | 13/16/13 |
Mark Lawson
BRD | Director/Board Member | 52 | 05/20/05 |
Grant Froese
BRD | Director/Board Member | 62 | 05/20/05 |
1st Jan change | Capi. | |
---|---|---|
+18.00% | 12TCr | |
+14.80% | 11TCr | |
-4.36% | 2.4TCr | |
+2.18% | 2.26TCr | |
-10.09% | 1.82TCr | |
-41.04% | 1.68TCr | |
-11.87% | 1.62TCr | |
+2.37% | 1.34TCr | |
+25.48% | 1.13TCr |